ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/alkylating-agent

Search results

target/alkylating-agent
52 trial(s) found.
NSW2109 - North Ryde - Macquarie University Hospital (SUSPENDED)
2050 - Camperdown - Chris O'Brien Lifehouse (COMPLETED)
VIC3000 - Melbourne - Peter MacCallum Cancer Centre (COMPLETED)3053 - Parkville - The Royal Women's Hospital and Institute of Maternal and Child Health (COMPLETED)
5037 - Kurralta Park - Icon Cancer Centre Adelaide (TERMINATED)
NSW2031 - Randwick - Sydney Children's Hospital (SUSPENDED)2145 - Westmead - The Children's Hospital at Westmead (SUSPENDED)2305 - New Lambton Heights - John Hunter Children's Hospital (SUSPENDED)
3168 - Clayton - Monash Medical Centre (SUSPENDED)
2145 - Westmead - The Children's Hospital at Westmead (SUSPENDED)
WA6009 - Perth - Perth Children's Hospital (SUSPENDED)
Filters
KIT
10%
CD20
10%
VEGFR2
8%
RET
8%
VEGFR
8%
AXL
6%
HIF2a
6%
MET
6%
PD-1
6%
PD-1/PD-L1
6%
ROS1
6%
VEGF
6%
PARP
6%
Trop2
6%
mTOR
6%
mTORC1
6%
Bcl2
6%
MER
4%
GD2
4%
PI3K
4%
PI3K delta
4%
PI3Kalpha
4%
mTORC2
4%
CD19
4%
CDK4
4%
CDK6
4%
cereblon
4%
FGFR
4%
FGFR1
4%
FGFR1/2/3
4%
FGFR2
4%
FGFR3
4%
FGFR4
4%
PDGFR
4%
IL-2
2%
LAT1
2%
LAT2
2%
ALK
2%
DPD
2%
orotate phosphoribosyltransferase
2%
LAG3
2%
B7H3
2%
IDH1
2%
IDH1 R132
2%
BCR-ABL1
2%
PDGFRA
2%
SRC
2%
YES1
2%
carbonic anhydrase
2%
IL-6
2%
ERBB2
2%
PARP1-selective
2%
ROR1
2%
ATM
2%
BTK
2%
AR
2%
CYP17A1
2%
HMG-CoA reductase
2%
androgen axis
2%
oestrogen axis
2%
XPO1
2%
proteasome
2%